ArticleProceedings of the National Academy of Sciences of the United States of America2009

E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction.

Gullu Gorgun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.